Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-03-07

Clinical Trial Update: Antineoplaston Therapy in Treating Children With Rhabdoid Tumor of the Central Nervous System [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating antineoplaston therapy for children with rhabdoid tumor of the central nervous system was terminated, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Antineoplaston therapy

Snippet

Sponsor: Burzynski Research Institute | Conditions: Rhabdoid Neoplasm of CNS | Phase 2 | Status: TERMINATED | Results posted: 2017-03-07